Worth Financial Advisory Group LLC Has $375,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Worth Financial Advisory Group LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 45.1% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 736 shares of the healthcare conglomerate’s stock after selling 604 shares during the quarter. Worth Financial Advisory Group LLC’s holdings in UnitedHealth Group were worth $375,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. International Assets Investment Management LLC increased its stake in shares of UnitedHealth Group by 1.9% in the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,352,000 after buying an additional 85 shares in the last quarter. GUNN & Co INVESTMENT MANAGEMENT INC. raised its stake in shares of UnitedHealth Group by 1,337.3% in the fourth quarter. GUNN & Co INVESTMENT MANAGEMENT INC. now owns 97,679 shares of the healthcare conglomerate’s stock worth $51,425,000 after acquiring an additional 90,883 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $701,000. Addison Advisors LLC raised its position in UnitedHealth Group by 23.0% in the 4th quarter. Addison Advisors LLC now owns 374 shares of the healthcare conglomerate’s stock worth $197,000 after purchasing an additional 70 shares during the last quarter. Finally, Valmark Advisers Inc. boosted its position in UnitedHealth Group by 5.6% in the 4th quarter. Valmark Advisers Inc. now owns 6,178 shares of the healthcare conglomerate’s stock valued at $3,252,000 after buying an additional 326 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on UNH shares. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Truist Financial lifted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Barclays lifted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Stock Performance

NYSE UNH traded up $0.22 during trading on Tuesday, reaching $587.35. 1,581,941 shares of the company’s stock were exchanged, compared to its average volume of 4,136,158. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The business has a 50 day moving average price of $539.79 and a 200-day moving average price of $510.36. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $592.34. The stock has a market capitalization of $542.37 billion, a P/E ratio of 35.90, a PEG ratio of 1.61 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the company posted $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.